Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Vancomycin for Cellulitis or Erysipelas
NCT00295178Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2006
- Primary completion
- Aug 2006
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in cellulitis, erysipelas, sponsored by Merck & Co.. Started Feb 2006; status: completed.
02
Drugs
daptomycin
03
Conditions
cellulitiserysipelas
Beyond the preview
Go deeper on NCT00295178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295178.